Page last updated: 2024-08-05 12:52:02
peptide zwitterion
Zwitterionic form of any peptide where, in general, the amino terminus is positively charged and the carboxy terminus is negatively charged.
ChEBI ID: 60466
Members (7)
| Member | Definition | Role |
|---|---|---|
| aglucovancomycin b | A peptide zwitterion obtained by transfer of a proton from the carboxy to the amino group of vancomycin aglycone. | vancomycin aglycone zwitterion; vancomycin aglycone |
| angiotensin i | A peptide zwitterion that is the dizwitterionic form of angiotensin (1-9) having both carboxy groups deprotonated and the aspartyl amino group and arginine side-chain protonated. It is the major species at pH 7.3. | angiotensin (1-9) dizwitterion; angiotensin (1-9) |
| angiotensin i | A peptide zwitterion that is the dizwitterionic form of angiotensin I having both carboxy groups deprotonated and the aspartyl amino group and arginine side-chain protonated. It is the major species at pH 7.3. | angiotensin I dizwitterion; angiotensin I |
| angiotensin i, ile(5)- | A peptide zwitterion that is the dizwitterionic form of angiotensin I having both carboxy groups deprotonated and the aspartyl amino group and arginine side-chain protonated. It is the major species at pH 7.3. | angiotensin I dizwitterion; angiotensin I |
| enkephalin, leucine | A peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Leu-enkephalin. Major species at pH 7.3. | Leu-enkephalin zwitterion; Leu-enkephalin |
| enkephalin, methionine | A peptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Met-enkephalin. Major species at pH 7.3. | Met-enkephalin zwitterion; Met-enkephalin |
| neurotensin (1-8) | A peptide zwitterion that is the dizwitterionic form of neurotensin (1-8) having both carboxy groups deprotonated and the side-chains of L-lysyl and L-arginine protonated. It is the major species at pH 7.3. | neurotensin (1-8) dizwitterion; neurotensin (1-8) |
Research
Studies (14,888)
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5,948 (39.95) | 18.7374 |
| 1990's | 4,695 (31.54) | 18.2507 |
| 2000's | 2,052 (13.78) | 29.6817 |
| 2010's | 1,769 (11.88) | 24.3611 |
| 2020's | 424 (2.85) | 2.80 |
Study Types
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 205 (1.30%) | 5.53% |
| Reviews | 1,062 (6.71%) | 6.00% |
| Case Studies | 65 (0.41%) | 4.05% |
| Observational | 14 (0.09%) | 0.25% |
| Other | 14,473 (91.49%) | 84.16% |